《沪深两市》上证深成均高开0.3% 券商股造好
据报人行今进行1,400亿人币7天期逆回购操作,上证深成双双高开。上证今早高开10点或0.3%,报3,348点;深成高开34点或0.3%,报13,280点;沪深300指数高开13点或0.3%,报4,750;创业板指数高开9点或0.4%,报2,605。
建行(601939.SH)开市後表现向好,现升0.3%。国联证券(601456.SH)拟换股吸收合并国金证券(600109.SH),双方今日起停牌。一众券商股造好,浙商证券(601878.SH)涨停。中银证券(601696.SH)涨停。华创阳安(600155.SH)、天风证券(601162.SH)、南京证券(601990.SH)升2.2%-4.2%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.